RxCues "The Permanent Address for Every Medicine"
A new online listing platform exclusively designed for promotion of Pharmaceutical and other Licensed Medical Products. It's unique for listing of medicines.
End users ( Consumers ) can easily search the available medical products from all different companies ( as the listing grows ) and sort them based on quality and cost. They can have alternative list of products with similar contents and sort them as per requirement and availability.
It is useful for the promotion of unique branded products especially for small research firms with small marketing budgets. Manufacturers can list down their product catalogue at free of cost.
The criteria for search is based on either brand name or content with its strength. One can easily find the detailed listing of products with similar contents by just single click.
A new online listing platform exclusively designed for promotion of Pharmaceutical and other Licensed Medical Products. It's unique for listing of medicines.
End users ( Consumers ) can easily search the available medical products from all different companies ( as the listing grows ) and sort them based on quality and cost. They can have alternative list of products with similar contents and sort them as per requirement and availability.
It is useful for the promotion of unique branded products especially for small research firms with small marketing budgets. Manufacturers can list down their product catalogue at free of cost.
The criteria for search is based on either brand name or content with its strength. One can easily find the detailed listing of products with similar contents by just single click.
• Abbott Laboratories (ABT) Paid CEO More Than Taxes to Uncle Sam More...
• Cipla Medpro Suspends CEO for "Serious" Charges More...
• Myrexis, Inc. Announces Death of Chief Executive Officer Richard B. Brewer, Trailblazing Biotechnology Industry Veteran and Patient Advocate More...
• Forty Year Industry Veteran Randall E. Woods Named CEO at Sophiris Bio More...
• Dr. Harold Schoenhaus Joins the Scientific Advisory Board of Alliqua, Inc. (Formerly known as HepaLife Technologies Inc.) (ALQA) More...
• Fluidigm Corporation Prices $52.2 Million Public Offering of Common Stock More...
• Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, Creates Itonis Pharmaceuticals, a New Division of Itonis, Inc. More...
• TG Therapeutics, Inc., Rhizen Pharmaceuticals Ink Deal Worth Up to $250 Million More...
• Biogen Idec, Inc. (Massachusetts) (BIIB), Regulus Therapeutics, Inc. Cut Deal to Monitor MS More...
• BioTime (BTX) and OncoCyte Corporation Publish Data on the Gene COL10A1 as a Marker and Potential Diagnostic for a Wide Array of Human Cancers More...
• DARA BioSciences, Inc. Announces Soltamox® Distribution Partnership in the Commonwealth of Puerto Rico More...
• Quotient Biodiagnostics Signs 36 Month Agreement With the Premier Healthcare Alliance to Supply Blood Bank Reagents to Its 2,600 Member Hospitals More...
• Bio-Path Holdings, Inc. (BPTH) Reports Second Quarter 2012 Operational and Financial Results More...
• Genmab A/S (GEN.CO) Announces Financial Results for the First Half 2012 and Improves 2012 Financial Guidance More...
• Navidea Biopharmaceuticals (NEOP) Announces 2012 Annual Meeting Results More...
• Probi: Lower Second-Quarter Income but Continued Growth for Full-Year 2012 More...
• Perrigo Company (PRGO) Reports Record Fourth Quarter and Fiscal Year Revenue, Earnings and Cash Flow From Operations More...
• ImmusanT, Inc. Relocates Offices to State-of-the-Art Innovation Facility More...
• Idenix Pharmaceuticals, Inc. (IDIX) Shares Plunge on Hep C Tx Heart Fears More...
• Novartis AG (NVS) Eye Drug Shows Promise in Study More...
• Pfizer Inc. (PFE)'s Experimental Drug Works in Ulcerative Colitis More...
• The New England Journal of Medicine Publishes Results From The New England Journal of Medicine and Medivation, Inc. (MDVN)'s Phase 3 AFFIRM Trial of Enzalutamide More...
• Pluristem Therapeutics (PSTI) Receives Approval From Indian Ministry of Health for Use of PLX Cells in Phase II Trial for Treatment of Buerger's Disease More...
• FDA: Codeine Can be Fatal to Some Children More...
• Pharmalucence, Inc. Announces FDA Approval and Orphan Drug Designation for Use of Sulfur Colloid Injection to Locate Lymph Nodes in Malignant Melanoma Patients More...
• IMPAX Laboratories, Inc. (IPXL) Hopes Parkinson's Drug is a Game Changer More...
• Apexigen Announces the Filing of an IND by its Partner, 3SBio Inc. (SSRX) More...
• Dark Chocolate May Help Lower Blood Pressure, National Institute of Integrative Medicine Study More...
• New Drug Extends Life in Men With Advanced Prostate Cancer Patients, Memorial Sloan-Kettering Cancer Center Study More...
• Babies May Not Have a "Moral Compass" After All, University of Otago Study More...
• Gut Bacteria Linked to Obesity and Metabolic Syndrome Identified, University of Maryland School of Medicine Study More...
• Cipla Medpro Suspends CEO for "Serious" Charges More...
• Myrexis, Inc. Announces Death of Chief Executive Officer Richard B. Brewer, Trailblazing Biotechnology Industry Veteran and Patient Advocate More...
• Forty Year Industry Veteran Randall E. Woods Named CEO at Sophiris Bio More...
• Dr. Harold Schoenhaus Joins the Scientific Advisory Board of Alliqua, Inc. (Formerly known as HepaLife Technologies Inc.) (ALQA) More...
• Fluidigm Corporation Prices $52.2 Million Public Offering of Common Stock More...
• Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, Creates Itonis Pharmaceuticals, a New Division of Itonis, Inc. More...
• TG Therapeutics, Inc., Rhizen Pharmaceuticals Ink Deal Worth Up to $250 Million More...
• Biogen Idec, Inc. (Massachusetts) (BIIB), Regulus Therapeutics, Inc. Cut Deal to Monitor MS More...
• BioTime (BTX) and OncoCyte Corporation Publish Data on the Gene COL10A1 as a Marker and Potential Diagnostic for a Wide Array of Human Cancers More...
• DARA BioSciences, Inc. Announces Soltamox® Distribution Partnership in the Commonwealth of Puerto Rico More...
• Quotient Biodiagnostics Signs 36 Month Agreement With the Premier Healthcare Alliance to Supply Blood Bank Reagents to Its 2,600 Member Hospitals More...
• Bio-Path Holdings, Inc. (BPTH) Reports Second Quarter 2012 Operational and Financial Results More...
• Genmab A/S (GEN.CO) Announces Financial Results for the First Half 2012 and Improves 2012 Financial Guidance More...
• Navidea Biopharmaceuticals (NEOP) Announces 2012 Annual Meeting Results More...
• Probi: Lower Second-Quarter Income but Continued Growth for Full-Year 2012 More...
• Perrigo Company (PRGO) Reports Record Fourth Quarter and Fiscal Year Revenue, Earnings and Cash Flow From Operations More...
• ImmusanT, Inc. Relocates Offices to State-of-the-Art Innovation Facility More...
• Idenix Pharmaceuticals, Inc. (IDIX) Shares Plunge on Hep C Tx Heart Fears More...
• Novartis AG (NVS) Eye Drug Shows Promise in Study More...
• Pfizer Inc. (PFE)'s Experimental Drug Works in Ulcerative Colitis More...
• The New England Journal of Medicine Publishes Results From The New England Journal of Medicine and Medivation, Inc. (MDVN)'s Phase 3 AFFIRM Trial of Enzalutamide More...
• Pluristem Therapeutics (PSTI) Receives Approval From Indian Ministry of Health for Use of PLX Cells in Phase II Trial for Treatment of Buerger's Disease More...
• FDA: Codeine Can be Fatal to Some Children More...
• Pharmalucence, Inc. Announces FDA Approval and Orphan Drug Designation for Use of Sulfur Colloid Injection to Locate Lymph Nodes in Malignant Melanoma Patients More...
• IMPAX Laboratories, Inc. (IPXL) Hopes Parkinson's Drug is a Game Changer More...
• Apexigen Announces the Filing of an IND by its Partner, 3SBio Inc. (SSRX) More...
• Dark Chocolate May Help Lower Blood Pressure, National Institute of Integrative Medicine Study More...
• New Drug Extends Life in Men With Advanced Prostate Cancer Patients, Memorial Sloan-Kettering Cancer Center Study More...
• Babies May Not Have a "Moral Compass" After All, University of Otago Study More...
• Gut Bacteria Linked to Obesity and Metabolic Syndrome Identified, University of Maryland School of Medicine Study More...
• Ex-Genentech (RHHBY) Staffer Cites Reckless R&D Practices More...
• Icahn Slams Forest Laboratories, Inc. (FRX) Over FDA Warning Letter More...
• Onconova Therapeutics Inc. Logs $50 Million More...
• Kineta Inc. Pulls in $5.8 Million for Autoimmune Drug More...
• Upsher-Smith Laboratories Completes Acquisition of Proximagen Group plc. More...
• Cortex Pharmaceuticals, Inc. (COR) and Pier Pharmaceuticals Consummate Merger More...
• IMS Health (RX) Expands Suite of Syndicated, Web-based Analytics With Acquisition of PharmaDeals Ltd. More...
• Pfizer Inc. (PFE) to Pay $250 Million to AstraZeneca PLC (AZN) for OTC Nexium Marketing Rights More...
• Arrowhead Research Corporation (ARWR) Enters Into Antibody Candidate Evaluation Agreement With Merck & Co., Inc. (MRK) More...
• Plasticell and EMD Millipore Complete Licensing Deal to Distribute Fully Defined, Xeno-Free Mesenchymal Stem Cell Differentiation Media More...
• Bioniche Life Sciences Inc. (BNC) Enters Into an Exclusive U.S. Distribution Agreement for an Equine Product More...
• Zenobia Therapeutics, Inc. Announce a Partnership With the Alzheimer's Drug Discovery Foundation More...
• Dynavax Technologies Corporation (DVAX) AppointsChristine Larson as Chief Financial Officer More...
• ADVENTRX Pharmaceuticals Inc. (ANX) Announces Appointment of Chief Medical Officer More...
• Pharmacyclics, Inc. (PCYC) Appoints Joshua T. BrummExecutive Vice President of Finance More...
• Patheon Inc. (PTI.TO) Announces a Change to Its PDS Management Structure More...
• Array BioPharma, Inc. (ARRY) Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 More...
• Athersys, Inc. Reports Second Quarter 2012 Results More...
• Bioanalytical Systems, Inc. (BASI) Returns to Profitability Before Restructuring Charges for The Third Quarter Of Fiscal 2012 More...
• Celsion Corporation (CLN) Reports Second Quarter 2012 Financial Results and Business Update More...
• Derma Sciences, Inc. (DSCI) Reports Second Quarter 2012 Financial Results More...
• Shire plc (SHPG) May Leave Wayne to Brace for Potential Expansion More...
• Morphotek Inc. Opening Factory in Exton More...
• FDA Approves New Flu Vaccine for Upcoming Season More...
• Aegerion Pharmaceuticals, Inc. Scores a Date With the FDA More...
• Santarus Inc. (SNTS) Announces FDA Extension of UCERIS New Drug Application Target Action Date to January 16, 2013 More...
• Hemispherx Biopharma (HEB) Release: FDA Accepts Complete Response Submission Regarding the Ampligen® New Drug Application for Chronic Fatigue Syndrome More...
• Biovest International, Inc. Conducts End of Phase III Review With FDA of BiovaxID as Consolidation Therapy in Non-Hodgkin's Lymphoma More...
• Spectrum Pharmaceuticals, Inc. (SPPI) Commences Patient Enrollment in Randomized Phase 2b Clinical Trial of Ozarelix for Hormone-Dependent Prostate Cancer More...
• Coronado Biosciences Initiates Phase 2 Clinical Trial of TSO for the Treatment of Crohn's Disease More...
• Synergy Pharmaceuticals Completes Screening and Planned Enrollment in Phase IIb/III Study in Chronic Idiopathic Constipation Patients More...
• Proteonomix, Inc. (PROT) Receives FDA Permission to Initiate Company-Sponsored Phase 1 Clinical Trial With UMK-121 in Patients with End-Stage Liver Disease More...
• Egg Yolks as Bad as Smoking for Heart, London Health Sciences Centre's University Hospital Study More...
• Snoring in Toddlers Could be Sign of Behavioral Problems, Cincinnati Children's Hospital Medical Center Study More...
• Elderly Brains Get a Boost From Dark Chocolate, University of L'Aquila Study More...
• Why Are People Overconfident So Often? University of Navarra Study More...
• TONIX Pharmaceuticals, Inc. Reports That Sublingual Formulation of Fibromyalgia Drug Reduces Production of a Psychoactive Metabolite, Improving Suitability for Long-Term, Chronic Treatment More...
• OncoNatural Solutions Release: Over-the-Counter Prostate Treatment PHC® Awarded U.S. Patent More...
• Aptalis Pharmaceutical Technologies Announces U.S. Commercial Availability of VIOKACE (Pancrelipase) Tablets More...
• Icahn Slams Forest Laboratories, Inc. (FRX) Over FDA Warning Letter More...
• Onconova Therapeutics Inc. Logs $50 Million More...
• Kineta Inc. Pulls in $5.8 Million for Autoimmune Drug More...
• Upsher-Smith Laboratories Completes Acquisition of Proximagen Group plc. More...
• Cortex Pharmaceuticals, Inc. (COR) and Pier Pharmaceuticals Consummate Merger More...
• IMS Health (RX) Expands Suite of Syndicated, Web-based Analytics With Acquisition of PharmaDeals Ltd. More...
• Pfizer Inc. (PFE) to Pay $250 Million to AstraZeneca PLC (AZN) for OTC Nexium Marketing Rights More...
• Arrowhead Research Corporation (ARWR) Enters Into Antibody Candidate Evaluation Agreement With Merck & Co., Inc. (MRK) More...
• Plasticell and EMD Millipore Complete Licensing Deal to Distribute Fully Defined, Xeno-Free Mesenchymal Stem Cell Differentiation Media More...
• Bioniche Life Sciences Inc. (BNC) Enters Into an Exclusive U.S. Distribution Agreement for an Equine Product More...
• Zenobia Therapeutics, Inc. Announce a Partnership With the Alzheimer's Drug Discovery Foundation More...
• Dynavax Technologies Corporation (DVAX) AppointsChristine Larson as Chief Financial Officer More...
• ADVENTRX Pharmaceuticals Inc. (ANX) Announces Appointment of Chief Medical Officer More...
• Pharmacyclics, Inc. (PCYC) Appoints Joshua T. BrummExecutive Vice President of Finance More...
• Patheon Inc. (PTI.TO) Announces a Change to Its PDS Management Structure More...
• Array BioPharma, Inc. (ARRY) Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 More...
• Athersys, Inc. Reports Second Quarter 2012 Results More...
• Bioanalytical Systems, Inc. (BASI) Returns to Profitability Before Restructuring Charges for The Third Quarter Of Fiscal 2012 More...
• Celsion Corporation (CLN) Reports Second Quarter 2012 Financial Results and Business Update More...
• Derma Sciences, Inc. (DSCI) Reports Second Quarter 2012 Financial Results More...
• Shire plc (SHPG) May Leave Wayne to Brace for Potential Expansion More...
• Morphotek Inc. Opening Factory in Exton More...
• FDA Approves New Flu Vaccine for Upcoming Season More...
• Aegerion Pharmaceuticals, Inc. Scores a Date With the FDA More...
• Santarus Inc. (SNTS) Announces FDA Extension of UCERIS New Drug Application Target Action Date to January 16, 2013 More...
• Hemispherx Biopharma (HEB) Release: FDA Accepts Complete Response Submission Regarding the Ampligen® New Drug Application for Chronic Fatigue Syndrome More...
• Biovest International, Inc. Conducts End of Phase III Review With FDA of BiovaxID as Consolidation Therapy in Non-Hodgkin's Lymphoma More...
• Spectrum Pharmaceuticals, Inc. (SPPI) Commences Patient Enrollment in Randomized Phase 2b Clinical Trial of Ozarelix for Hormone-Dependent Prostate Cancer More...
• Coronado Biosciences Initiates Phase 2 Clinical Trial of TSO for the Treatment of Crohn's Disease More...
• Synergy Pharmaceuticals Completes Screening and Planned Enrollment in Phase IIb/III Study in Chronic Idiopathic Constipation Patients More...
• Proteonomix, Inc. (PROT) Receives FDA Permission to Initiate Company-Sponsored Phase 1 Clinical Trial With UMK-121 in Patients with End-Stage Liver Disease More...
• Egg Yolks as Bad as Smoking for Heart, London Health Sciences Centre's University Hospital Study More...
• Snoring in Toddlers Could be Sign of Behavioral Problems, Cincinnati Children's Hospital Medical Center Study More...
• Elderly Brains Get a Boost From Dark Chocolate, University of L'Aquila Study More...
• Why Are People Overconfident So Often? University of Navarra Study More...
• TONIX Pharmaceuticals, Inc. Reports That Sublingual Formulation of Fibromyalgia Drug Reduces Production of a Psychoactive Metabolite, Improving Suitability for Long-Term, Chronic Treatment More...
• OncoNatural Solutions Release: Over-the-Counter Prostate Treatment PHC® Awarded U.S. Patent More...
• Aptalis Pharmaceutical Technologies Announces U.S. Commercial Availability of VIOKACE (Pancrelipase) Tablets More...
• Elan Corporation PLC (ELN) Cuts Loose Its R&D Unit More...
• Sanofi (France) (SAN.PA) Reorganization Enrages the French More...
• Pfizer Inc. (PFE) Unit Files for $100 Million IPO More...
• Relypsa, Inc. Raises $49.7 Million of $80 Million Funding Round More...
• Elcelyx Therapeutics Raises $4 Million More...
• Arrowhead Research Corporation (ARWR) Raises $6.2 Million Through Registered Direct Offering of Common Stock and Warrants More...
• Sun Pharmaceutical Industries Ltd to Take Taro Pharmaceutical Industries Ltd. (TARO) Private for $571 Million More...
• Quintiles, Inc. (QTRN) Acquires Expression Analysis, Inc., Premier Provider of Genomics Services, to Advance Personalized Medicine More...
• Pluristem Therapeutics (PSTI) Moves Intermittent Claudication Indication Forward in Europe Through Collaboration With Cato Research More...
• Sequenta's LymphoSIGHT Platform Included in Phase II Mantle Cell Lymphoma Clinical Trial More...
• Molecular Profiles and Onyx Scientific Limited Form Strategic Alliance Spanning Drug Discovery to Manufacture More...
• InSite Vision (ISV) & Merck & Co., Inc. (MRK) Amend Payment Terms of AzaSite® License Agreement More...
• NewBridge Pharmaceuticals Forms Partnership With Genomic Health, Inc. to Bring Novel Genomic Testing to Patients in Middle East, Africa, and Caspian Regions More...
• Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors More...
• AccelPath, Inc. Appoints Professor Leslie F. Greengard, M.D., Ph.D. to the Company's Medical Advisory Board More...
• Cytomedix Inc. (CMXI) to Host Second Quarter 2012 Financial Results Conference Call on Wednesday, August 15, 2012 More...
• Echo Therapeutics (ECTE) Announces Second Quarter 2012 Financial Results More...
• GeoVax Labs Inc. (GOVX.OB) Reports 2012 Second Quarter Financial Results More...
• Galectin Therapeutics Reports Second Quarter 2012 Financial Results More...
• ImmuCell (ICCC) Announces Profitable Financial Results More...
• Novo Nordisk A/S (NVO)'s Hemophilia Tx Could be a Total Bust More...
• Acorda Therapeutics (ACOR)' Ampyra Fails Main Goal of Post-Marketing Study More...
• Meritage Pharma Initiates Clinical Trial of Oral Budesonide Suspension for Adolescent and Adult Patients With Eosinophilic Esophagitis More...
• Protalix Biotherapeutics, Inc. (PLX) Receives FDA IND Clearance to Initiate a Phase I/II Study of Fabry Disease Patients With PRX-102, a Modified Enzyme Replacement Therapy More...
• Vernalis PLC (VNLPY.PK) to Present Positive Phase I Data for V158866 at14th World Congress on Pain More...
• FDA OKs Sanofi (France) (SAN.PA)'s Auvi-Q for Patients With Life-Threatening Allergic Reactions More...
• NPS Pharmaceuticals, Inc. (NPSP) Announces Extension of Action Date for Gattex® NDA to December 30, 2012 More...
• Teva Women's Health, Inc. (TEVA) Receives FDA Acceptance of Its New Drug Application for Quartette (Levonorgestrel/Ethinyl Estradiol Tablets and Ethinyl Estradiol tablets) for the Prevention of Pregnancy More...
• Daily Aspirin May Cut Cancer Deaths, Journal of the National Cancer Institute Reveals More...
• Migraines Do Not Hurt Your Brain, Brigham and Women's Hospital Study More...
• Smelling a Skunk After a Cold, Northwestern University Feinberg School of Medicine Study More...
• How Stress and Depression Can Shrink the Brain, Yale University Study More...
• Galena Biopharma (RXII) Issued Folate Binding Protein (FBP) Cancer Vaccine Patent in Japan More...
• Roche (RHHBY) Requested by National Institute for Clinical Excellence (NICE) to Provide Further Zelboraf Data More...
• Fresenius Kabi AG Threatens to Sue Doc Over Study More...
• Applied DNA Sciences, Inc. (APDN) SigNature® DNA Sends UK Thieves to Jail for 53 Years More...
• KV Pharmaceutical Wins a Makena Ruling in Georgia More...
• Sanofi (France) (SAN.PA) Reorganization Enrages the French More...
• Pfizer Inc. (PFE) Unit Files for $100 Million IPO More...
• Relypsa, Inc. Raises $49.7 Million of $80 Million Funding Round More...
• Elcelyx Therapeutics Raises $4 Million More...
• Arrowhead Research Corporation (ARWR) Raises $6.2 Million Through Registered Direct Offering of Common Stock and Warrants More...
• Sun Pharmaceutical Industries Ltd to Take Taro Pharmaceutical Industries Ltd. (TARO) Private for $571 Million More...
• Quintiles, Inc. (QTRN) Acquires Expression Analysis, Inc., Premier Provider of Genomics Services, to Advance Personalized Medicine More...
• Pluristem Therapeutics (PSTI) Moves Intermittent Claudication Indication Forward in Europe Through Collaboration With Cato Research More...
• Sequenta's LymphoSIGHT Platform Included in Phase II Mantle Cell Lymphoma Clinical Trial More...
• Molecular Profiles and Onyx Scientific Limited Form Strategic Alliance Spanning Drug Discovery to Manufacture More...
• InSite Vision (ISV) & Merck & Co., Inc. (MRK) Amend Payment Terms of AzaSite® License Agreement More...
• NewBridge Pharmaceuticals Forms Partnership With Genomic Health, Inc. to Bring Novel Genomic Testing to Patients in Middle East, Africa, and Caspian Regions More...
• Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors More...
• AccelPath, Inc. Appoints Professor Leslie F. Greengard, M.D., Ph.D. to the Company's Medical Advisory Board More...
• Cytomedix Inc. (CMXI) to Host Second Quarter 2012 Financial Results Conference Call on Wednesday, August 15, 2012 More...
• Echo Therapeutics (ECTE) Announces Second Quarter 2012 Financial Results More...
• GeoVax Labs Inc. (GOVX.OB) Reports 2012 Second Quarter Financial Results More...
• Galectin Therapeutics Reports Second Quarter 2012 Financial Results More...
• ImmuCell (ICCC) Announces Profitable Financial Results More...
• Novo Nordisk A/S (NVO)'s Hemophilia Tx Could be a Total Bust More...
• Acorda Therapeutics (ACOR)' Ampyra Fails Main Goal of Post-Marketing Study More...
• Meritage Pharma Initiates Clinical Trial of Oral Budesonide Suspension for Adolescent and Adult Patients With Eosinophilic Esophagitis More...
• Protalix Biotherapeutics, Inc. (PLX) Receives FDA IND Clearance to Initiate a Phase I/II Study of Fabry Disease Patients With PRX-102, a Modified Enzyme Replacement Therapy More...
• Vernalis PLC (VNLPY.PK) to Present Positive Phase I Data for V158866 at14th World Congress on Pain More...
• FDA OKs Sanofi (France) (SAN.PA)'s Auvi-Q for Patients With Life-Threatening Allergic Reactions More...
• NPS Pharmaceuticals, Inc. (NPSP) Announces Extension of Action Date for Gattex® NDA to December 30, 2012 More...
• Teva Women's Health, Inc. (TEVA) Receives FDA Acceptance of Its New Drug Application for Quartette (Levonorgestrel/Ethinyl Estradiol Tablets and Ethinyl Estradiol tablets) for the Prevention of Pregnancy More...
• Daily Aspirin May Cut Cancer Deaths, Journal of the National Cancer Institute Reveals More...
• Migraines Do Not Hurt Your Brain, Brigham and Women's Hospital Study More...
• Smelling a Skunk After a Cold, Northwestern University Feinberg School of Medicine Study More...
• University of Western Ontario Researchers Explore Secret Origin of Deja Vu More...
• How Stress and Depression Can Shrink the Brain, Yale University Study More...
• Galena Biopharma (RXII) Issued Folate Binding Protein (FBP) Cancer Vaccine Patent in Japan More...
• Roche (RHHBY) Requested by National Institute for Clinical Excellence (NICE) to Provide Further Zelboraf Data More...
• Fresenius Kabi AG Threatens to Sue Doc Over Study More...
• Applied DNA Sciences, Inc. (APDN) SigNature® DNA Sends UK Thieves to Jail for 53 Years More...
• KV Pharmaceutical Wins a Makena Ruling in Georgia More...
• Infinity Pharmaceuticals Inc. (INFI) to Slash Jobs More...
• Royal DSM to Cut 1,000 Jobs as Chief Strives to Meet Profit Goals More...
• Elan Corporation PLC (ELN) Faces an Even Shakier Future More...
• Pharming Group (PHGUF.PK) Draws First Tranche Under EUR10 Million Working Capital Facility More...
• MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) to Acquire Pracinostat for Up to $75.2 Million More...
• Warner Chilcott, PLC (WCRX) Ends Talks With Possible Buyers More...
• Bristol-Myers Squibb Company (BMY) Announces Successful Completion of Cash Tender Offer for Shares of Amylin Pharmaceuticals, Inc. (AMLN) More...
• DSM Buys Brazil Animal Nutrition Firm for 465 Million Euros More...
• Dudnyk Expands Offering Via Strategic Acquisition More...
• Lundbeck Inc. (LUN.CO) in Talks With Possible Alzheimer's Drug Partners More...
• Synthetic Biologics, Inc. (AEN) and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases More...
• Mylan Specialty, Pfizer Inc. (PFE) Sign EpiPen Injection Licensing Deal in Japan More...
• Islet Sciences Announces Strategic Alliance With Spring Point Project More...
• CollabRx Teams With MedPage Today to Introduce Digital Tool for Patient-Specific Genomic Approaches to Cancer Treatment More...
• AnaptysBio, Inc. Expands Leadership Team With Addition of Dr. Andrew J. Mcknight More...
• Lundbeck Inc. (LUN.CO) Posts Second-Quarter Loss on Restructuring Charge More...
• Apricus Biosciences (APRI) Announces Second Quarter 2012 Financial Results Conference Call and Provides Corporate Update More...
• Aegerion Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results More...
• Achillion Pharmaceuticals, Inc. (ACHN) Reports Second Quarter and Six Month 2012 Financial Results More...
• Amicus Therapeutics, Inc. (FOLD) Announces Second Quarter 2012 Financial Results & Corporate Updates More...
• Pfizer Inc. (PFE) to Pay $60 Million for Making Foreign Bribes More...
• K-V Pharmaceutical Company (KV-A) "First Day" Motions Approved by U.S. Bankruptcy Court More...
• Novartis AG (NVS) is Staying Put But Selling 12 Acres More...
Drug Trial Failure Hits AstraZeneca PLC (AZN), BTG plc (BGC.L) More...
• Head-to-Head Back Pain Study Finds No Difference Between Eli Lilly and Company (LLY)'s Forteo and Warner Chilcott, PLC (WCRX)'s Actonel More...
• Achillion Pharmaceuticals, Inc. (ACHN) Hepatitis C Drug Shows Promise in Mid-Stage Study More...
• Teva Pharmaceutical Industries Limited (TEVA) to Initiate Third Phase III Trial of Oral Laquinimod for the Treatment of Relapsing Remitting Multiple Sclerosis More...
• Omeros Corporation (OMER) Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial More...
• Eli Lilly and Company (LLY) Last Hope for Alzheimer's Drug as Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Pull Out More...
• Perrigo Company (PRGO) Receives FDA Approval and Commences Launch of Morphine Sulfate 100ml/5% Oral Solution More...
• Thinner Diabetics at Higher Death Risk, Northwestern University Feinberg School of Medicine Study More...
• Cholesterol Lowering Drug Can Up Risk of Cataract, University of Waterloo Study More...
• Corticosteroids Not Effective for Treating Acute Sinusitis, University Medical Center Utrecht Study More...
• Hormone May Boost Aging, Failing Brains, University of Washington and VA Puget Sound Health Care System Study More...
• Grapefruit Juice Lowers Dose of Cancer Drug, University of Chicago Study More...
• Did Ranbaxy Laboratories (RANBAXY.BO) Abandon Generic Provigil Launch? More...
• Quick-Med Technologies (QMDT) Announces Expanded Regulatory Clearance for Stay Fresh(R) Antimicrobial More...
• Royal DSM to Cut 1,000 Jobs as Chief Strives to Meet Profit Goals More...
• Elan Corporation PLC (ELN) Faces an Even Shakier Future More...
• Pharming Group (PHGUF.PK) Draws First Tranche Under EUR10 Million Working Capital Facility More...
• MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) to Acquire Pracinostat for Up to $75.2 Million More...
• Warner Chilcott, PLC (WCRX) Ends Talks With Possible Buyers More...
• Bristol-Myers Squibb Company (BMY) Announces Successful Completion of Cash Tender Offer for Shares of Amylin Pharmaceuticals, Inc. (AMLN) More...
• DSM Buys Brazil Animal Nutrition Firm for 465 Million Euros More...
• Dudnyk Expands Offering Via Strategic Acquisition More...
• Lundbeck Inc. (LUN.CO) in Talks With Possible Alzheimer's Drug Partners More...
• Synthetic Biologics, Inc. (AEN) and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases More...
• Mylan Specialty, Pfizer Inc. (PFE) Sign EpiPen Injection Licensing Deal in Japan More...
• Islet Sciences Announces Strategic Alliance With Spring Point Project More...
• CollabRx Teams With MedPage Today to Introduce Digital Tool for Patient-Specific Genomic Approaches to Cancer Treatment More...
• AnaptysBio, Inc. Expands Leadership Team With Addition of Dr. Andrew J. Mcknight More...
• Lundbeck Inc. (LUN.CO) Posts Second-Quarter Loss on Restructuring Charge More...
• Apricus Biosciences (APRI) Announces Second Quarter 2012 Financial Results Conference Call and Provides Corporate Update More...
• Aegerion Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results More...
• Achillion Pharmaceuticals, Inc. (ACHN) Reports Second Quarter and Six Month 2012 Financial Results More...
• Amicus Therapeutics, Inc. (FOLD) Announces Second Quarter 2012 Financial Results & Corporate Updates More...
• Pfizer Inc. (PFE) to Pay $60 Million for Making Foreign Bribes More...
• K-V Pharmaceutical Company (KV-A) "First Day" Motions Approved by U.S. Bankruptcy Court More...
• Novartis AG (NVS) is Staying Put But Selling 12 Acres More...
Drug Trial Failure Hits AstraZeneca PLC (AZN), BTG plc (BGC.L) More...
• Head-to-Head Back Pain Study Finds No Difference Between Eli Lilly and Company (LLY)'s Forteo and Warner Chilcott, PLC (WCRX)'s Actonel More...
• Achillion Pharmaceuticals, Inc. (ACHN) Hepatitis C Drug Shows Promise in Mid-Stage Study More...
• Teva Pharmaceutical Industries Limited (TEVA) to Initiate Third Phase III Trial of Oral Laquinimod for the Treatment of Relapsing Remitting Multiple Sclerosis More...
• Omeros Corporation (OMER) Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial More...
• Eli Lilly and Company (LLY) Last Hope for Alzheimer's Drug as Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Pull Out More...
• Perrigo Company (PRGO) Receives FDA Approval and Commences Launch of Morphine Sulfate 100ml/5% Oral Solution More...
• Thinner Diabetics at Higher Death Risk, Northwestern University Feinberg School of Medicine Study More...
• Cholesterol Lowering Drug Can Up Risk of Cataract, University of Waterloo Study More...
• Corticosteroids Not Effective for Treating Acute Sinusitis, University Medical Center Utrecht Study More...
• Hormone May Boost Aging, Failing Brains, University of Washington and VA Puget Sound Health Care System Study More...
• Grapefruit Juice Lowers Dose of Cancer Drug, University of Chicago Study More...
• Did Ranbaxy Laboratories (RANBAXY.BO) Abandon Generic Provigil Launch? More...
• Quick-Med Technologies (QMDT) Announces Expanded Regulatory Clearance for Stay Fresh(R) Antimicrobial More...
• Amneal Pharmaceuticals to Create 500 New Jobs More...
• Astellas Pharma Inc. (YPH.BE)'s Subsidiary Urogenix Inc. Shutting Down, 13 Scientists and Staff Affected More...
• KV Pharmaceutical Seeks Chap. 11 More...
• Proteros biostructures GmbH Announces Successful Close of 5 Million Euros More...
• GlaxoSmithKline (GSK) Completes $3.6 Billion Takeover of Human Genome Sciences, Inc. (HGSI) More...
• BC Partners to Acquire Aenova From Bridgepoint More...
• Kamada Ltd. (KMDA.TA) and Chiesi Farmaceutici SpA Enter into a Strategic Agreement for Up to $60 Million More...
• PharmaEngine, Inc. Nabs Rights to Nanobiotix's Nanoparticle Radiotherapy Booster for Up to $57 Million More...
• Novartis AG (NVS) Gets Immune-Cell Cancer Therapy in University of Pennsylvania Pact More...
• Tekmira Pharmaceuticals Corporation Provides Update on Collaboration With U.S. Government's TMT Program More...
• ACCU-BREAK Pharmaceuticals, Inc. Enters Into a Product Development and License Agreement With Alembic Pharmaceuticals Limited More...
• Nile Therapeutics, Inc. Promotes Darlene Horton, M.D., to Chief Executive Officer and Director More...
• Perreault Will Move Up to CEO of CSL Behring More...
• BioLargo, Inc. (BLGO.PK) Adds Wound Management Expert and Former VP at Smith & Nephew Inc. (SNN), Tanya Rhodes, to Its Team More...
• Champions Oncology, Inc. (CSBR) Reports Resignation of Director More...
• Eclipse Therapeutics, Inc., Sorrento Valley-Based Biotech Developing Innovative Cancer Therapeutics that Target Cancer Stem Cells, Appoints Patrick M. O'Connor, Ph.D. to Scientific Advisory Board More...
• Accellent Announces Timing of Second Quarter 2012 Earnings Release and Conference Call More...
• Celsion Corporation (CLN) to Hold Second Quarter 2012 Financial Results Conference Call on Tuesday, August 14, 2012 More...
• Cleveland Biolabs Inc. (CBLI) Reports Second Quarter 2012 Financial Results and Development Progress More...
• Cumberland Pharmaceuticals (CPIX) Reports Second Quarter 2012 Financial Results More...
• Depomed, Inc. (DEPO) Reports Second Quarter Financial Results More...
• Teva Pharmaceutical Industries Limited (TEVA) Subpoenaed Over Foreign Bribes More...
• U.S. Appeals Court Tosses Momenta Pharmaceuticals, Inc. (MNTA) Injunction Against Generic Lovenox More...
• CoreRx Opens Brand New 35,000 sq. ft. State-of-the-Art Facility More...
• FDA OKs First Generic Copies of Merck & Co., Inc. (MRK)'s Singulair More...
• Medivation, Inc. (MDVN) and Astellas Pharma Inc. (YPH.BE) Get PDUFA Date for Prostate Cancer Drug More...
• OXiGENE (OXGN) Announces Phase 2 Ovarian Cancer Trial of ZYBRESTAT® Plus Bevacizumab Achieves Important Interim Safety Objective More...
• TWi Pharmaceuticals, Inc. Announces Positive Phase IIb Clinical Trial Results of AC-201 in Patients With Type 2 Diabetes. More...
• Cellceutix (CTIX) Reports Its Very Novel Anti-Cancer Agent, Kevetrin, at Dana-Farber Cancer Institute for Start of Clinical Trials More...
• Alnylam Pharmaceuticals (ALNY) Presents New Data From Its Conjugate Delivery Platform, Enabling Subcutaneous Administration of RNAi Therapeutics With Wide Therapeutic Index More...
• Rexahn Pharmaceuticals, Inc. Completes Exploratory Phase I Clinical Study of RX-3117 More...
• The Way Your Pupils Dilate May Show Sexual Preference, Cornell University Study More...
• Carbon Monoxide's Damaging Role in Heart Rhythm Found, Leeds University Study More...
• Memory Improves for Older Adults Using Computerized Brain Fitness Program,University of California, Los Angeles (UCLA) Study More...
• Bilingualism "Can Increase Mental Agility," University of Strathclyde Study More...
• Honey May Ease Nighttime Coughing in Kids, Tel Aviv University Study More...
• Biostar Pharmaceuticals, Inc. (BSPM) Receives Approval From Xianyang SFDA to Restart Sales of Its Gel Capsule Drugs More...
• Mylan Inc. (MYL) Launches Generic Version of Amidate® Injection More...
• Qualitest Pharmaceuticals Launches Generic Singulair® More...
• Astellas Pharma Inc. (YPH.BE)'s Subsidiary Urogenix Inc. Shutting Down, 13 Scientists and Staff Affected More...
• KV Pharmaceutical Seeks Chap. 11 More...
• Proteros biostructures GmbH Announces Successful Close of 5 Million Euros More...
• GlaxoSmithKline (GSK) Completes $3.6 Billion Takeover of Human Genome Sciences, Inc. (HGSI) More...
• BC Partners to Acquire Aenova From Bridgepoint More...
• Kamada Ltd. (KMDA.TA) and Chiesi Farmaceutici SpA Enter into a Strategic Agreement for Up to $60 Million More...
• PharmaEngine, Inc. Nabs Rights to Nanobiotix's Nanoparticle Radiotherapy Booster for Up to $57 Million More...
• Novartis AG (NVS) Gets Immune-Cell Cancer Therapy in University of Pennsylvania Pact More...
• Tekmira Pharmaceuticals Corporation Provides Update on Collaboration With U.S. Government's TMT Program More...
• ACCU-BREAK Pharmaceuticals, Inc. Enters Into a Product Development and License Agreement With Alembic Pharmaceuticals Limited More...
• Nile Therapeutics, Inc. Promotes Darlene Horton, M.D., to Chief Executive Officer and Director More...
• Perreault Will Move Up to CEO of CSL Behring More...
• BioLargo, Inc. (BLGO.PK) Adds Wound Management Expert and Former VP at Smith & Nephew Inc. (SNN), Tanya Rhodes, to Its Team More...
• Champions Oncology, Inc. (CSBR) Reports Resignation of Director More...
• Eclipse Therapeutics, Inc., Sorrento Valley-Based Biotech Developing Innovative Cancer Therapeutics that Target Cancer Stem Cells, Appoints Patrick M. O'Connor, Ph.D. to Scientific Advisory Board More...
• Accellent Announces Timing of Second Quarter 2012 Earnings Release and Conference Call More...
• Celsion Corporation (CLN) to Hold Second Quarter 2012 Financial Results Conference Call on Tuesday, August 14, 2012 More...
• Cleveland Biolabs Inc. (CBLI) Reports Second Quarter 2012 Financial Results and Development Progress More...
• Cumberland Pharmaceuticals (CPIX) Reports Second Quarter 2012 Financial Results More...
• Depomed, Inc. (DEPO) Reports Second Quarter Financial Results More...
• Teva Pharmaceutical Industries Limited (TEVA) Subpoenaed Over Foreign Bribes More...
• U.S. Appeals Court Tosses Momenta Pharmaceuticals, Inc. (MNTA) Injunction Against Generic Lovenox More...
• CoreRx Opens Brand New 35,000 sq. ft. State-of-the-Art Facility More...
• FDA OKs First Generic Copies of Merck & Co., Inc. (MRK)'s Singulair More...
• Medivation, Inc. (MDVN) and Astellas Pharma Inc. (YPH.BE) Get PDUFA Date for Prostate Cancer Drug More...
• OXiGENE (OXGN) Announces Phase 2 Ovarian Cancer Trial of ZYBRESTAT® Plus Bevacizumab Achieves Important Interim Safety Objective More...
• TWi Pharmaceuticals, Inc. Announces Positive Phase IIb Clinical Trial Results of AC-201 in Patients With Type 2 Diabetes. More...
• Cellceutix (CTIX) Reports Its Very Novel Anti-Cancer Agent, Kevetrin, at Dana-Farber Cancer Institute for Start of Clinical Trials More...
• Alnylam Pharmaceuticals (ALNY) Presents New Data From Its Conjugate Delivery Platform, Enabling Subcutaneous Administration of RNAi Therapeutics With Wide Therapeutic Index More...
• Rexahn Pharmaceuticals, Inc. Completes Exploratory Phase I Clinical Study of RX-3117 More...
• The Way Your Pupils Dilate May Show Sexual Preference, Cornell University Study More...
• Carbon Monoxide's Damaging Role in Heart Rhythm Found, Leeds University Study More...
• Memory Improves for Older Adults Using Computerized Brain Fitness Program,University of California, Los Angeles (UCLA) Study More...
• Bilingualism "Can Increase Mental Agility," University of Strathclyde Study More...
• Honey May Ease Nighttime Coughing in Kids, Tel Aviv University Study More...
• Biostar Pharmaceuticals, Inc. (BSPM) Receives Approval From Xianyang SFDA to Restart Sales of Its Gel Capsule Drugs More...
• Mylan Inc. (MYL) Launches Generic Version of Amidate® Injection More...
• Qualitest Pharmaceuticals Launches Generic Singulair® More...
• FDA Rejects Regeneron Pharmaceuticals, Inc. (REGN)'s Arcalyst for Gout More...
• Arena Pharmaceuticals, Inc. (ARNA) Transfers Diet Pill Application to Eisai Company, Ltd. (ESALY.PK) More...
• FDA Accepts NuPathe Inc. (PATH)'s Migraine Patch NDA Resubmission for Filing More...
• Ariad Pharmaceuticals, Inc. (ARIA) Announces Submission of New Drug Application for Ponatinib to the FDA More...
• Vertex Pharmaceuticals Incorporated (VRTX) Lowers Incivek View; New Drug Data Lifts Shares More...
• Nymox Pharmaceutical (NYMX) Reports Positive Results From Combined Statistical Analysis of Long Term Follow-Up Studies of BPH Drug More...
• Rockwell Medical Technologies (RMTI) Completes Patient Enrollment in Phase III Clinical Trials for SFP Iron-Delivery in Hemodialysis Patients More...
• Pfizer Inc. (PFE) Announces Positive Top-Line Results From the ORAL Start Phase 3 Study of Tofacitinib in Rheumatoid Arthritis More...
• FDA Requests Teleconference to Discuss Repros Therapeutics Inc. (RPRX) Phase 2 Protocol for Proellex® in the Treatment of Endometriosis Last Week of August More...
• Mindreading Hormone? A Better Judge of Character With Nasal Spray? University of Oslo Study More...
• Rejected Alzheimer's Drug Shows New Potential, Mount Sinai School of Medicine Study More...
• Brains are Different in People With Highly Superior Autobiographical Memory,University of California, Irvine Study More...
• Computer Scientists Present Smile Database, University of Amsterdam Study More...
• Brain Development Delayed in ADHD, National Institutes of Health (NIH) Study More...
• StemCells Inc. (STEM) Broadens HuCNS-SC® Patent Portfolio With Key Patent in Japan More...
• GeNO LLC Receives Two Additional Patents For Inhaled Nitric Oxide Drug Delivery More...
• Abon Announces CLOLAR® Patent Challenge More...
• GlaxoSmithKline (GSK) Shipping U.S. Flu Vaccine With New Strain Coverage Recommended for 2012-2013 More...
• Mersana Therapeutics, Inc. Raises $27 Million to Advance Antibody-drug Conjugates More...
• Ultragenyx Raises $15 Million Toward $30 Million Goal More...
• CytomX Therapeutics, Inc. Expands Series B Financing; Canaan PartnersJoins Syndicate More...
• CMC Biologics Acquires XOMA Corporation (XOMA)'s Bay Area Manufacturing Facility More...
• CytoDyn Announces Entry into Agreement With Progenics Pharmaceuticals, Inc. (PGNX) to Acquire PRO 140 More...
• Idenix Pharmaceuticals, Inc. (IDIX) Regains Drug Rights From Partner Novartis AG (NVS) More...
• PolyMedix Inc. (PYMX.OB) and University of Pennsylvania Collaborate to Develop New Class of Defensin-Mimetic Antimicrobial Compounds to Treat Malaria More...
• Furiex Pharmaceuticals, Inc. (FURX) Announces Closing of Priligy® Asset Transfer and License Agreements More...
• Oncobiologics Inc. Announces a Collaboration Agreement with XOMA Corporation (XOMA) to Utilize XOMA's Fully Human Antibody Libraries for Their Discovery Platform More...
• Anchor Therapeutics Enters Into Collaborative Research Agreement With Kyowa Hakko Kirin for its Pepducin Technology More...
• KV Pharmaceutical CEO Gets Hefty Raise, Despite All the Problems More...
• Soren Tulstrup to Lead Shire plc (SHPG) HGT's MPS Franchise More...
• Cytovance Biologics Inc. Announces Don Wuchterl as Senior Vice President of Manufacturing Operations More...
• Quick-Med Technologies (QMDT) Appoints Bernd Liesenfeld as President More...
• A.P. Pharma, Inc. (APPA) Appoints Robert Rosen to Its Board of Directors More...
• Bayer AG (BAY.F) Lifts Guidance, Provisions Weigh on Earnings More...
• Acura Pharmaceuticals, Inc. (ACUR) Announces Second Quarter 2012 Financial Results More...
• Agennix AG Reports Financial Results for Second Quarter and First Half of 2012 More...
• Amarin Corporation PLC (AMRN) to Report Second Quarter 2012 Financial Results and Host Conference Call on August 8, 2012 More...
• Acasti Pharma First Quarter Results More...
• Teva Pharmaceutical Industries Limited (TEVA) Sues Genzyme Corporation (GENZ) for Poaching Employees More...
• EU Antitrust Charge for Servier, Teva Pharmaceutical Industries Limited (TEVA), Others Over Generics More...
• Immunovative Inc. Announces the Retention of Winston & Strawn LLP as Its Legal Counsel More...
• Arena Pharmaceuticals, Inc. (ARNA) Transfers Diet Pill Application to Eisai Company, Ltd. (ESALY.PK) More...
• FDA Accepts NuPathe Inc. (PATH)'s Migraine Patch NDA Resubmission for Filing More...
• Ariad Pharmaceuticals, Inc. (ARIA) Announces Submission of New Drug Application for Ponatinib to the FDA More...
• Vertex Pharmaceuticals Incorporated (VRTX) Lowers Incivek View; New Drug Data Lifts Shares More...
• Nymox Pharmaceutical (NYMX) Reports Positive Results From Combined Statistical Analysis of Long Term Follow-Up Studies of BPH Drug More...
• Rockwell Medical Technologies (RMTI) Completes Patient Enrollment in Phase III Clinical Trials for SFP Iron-Delivery in Hemodialysis Patients More...
• Pfizer Inc. (PFE) Announces Positive Top-Line Results From the ORAL Start Phase 3 Study of Tofacitinib in Rheumatoid Arthritis More...
• FDA Requests Teleconference to Discuss Repros Therapeutics Inc. (RPRX) Phase 2 Protocol for Proellex® in the Treatment of Endometriosis Last Week of August More...
• Mindreading Hormone? A Better Judge of Character With Nasal Spray? University of Oslo Study More...
• Rejected Alzheimer's Drug Shows New Potential, Mount Sinai School of Medicine Study More...
• Brains are Different in People With Highly Superior Autobiographical Memory,University of California, Irvine Study More...
• Computer Scientists Present Smile Database, University of Amsterdam Study More...
• Brain Development Delayed in ADHD, National Institutes of Health (NIH) Study More...
• StemCells Inc. (STEM) Broadens HuCNS-SC® Patent Portfolio With Key Patent in Japan More...
• GeNO LLC Receives Two Additional Patents For Inhaled Nitric Oxide Drug Delivery More...
• Abon Announces CLOLAR® Patent Challenge More...
• GlaxoSmithKline (GSK) Shipping U.S. Flu Vaccine With New Strain Coverage Recommended for 2012-2013 More...
• Mersana Therapeutics, Inc. Raises $27 Million to Advance Antibody-drug Conjugates More...
• Ultragenyx Raises $15 Million Toward $30 Million Goal More...
• CytomX Therapeutics, Inc. Expands Series B Financing; Canaan PartnersJoins Syndicate More...
• CMC Biologics Acquires XOMA Corporation (XOMA)'s Bay Area Manufacturing Facility More...
• CytoDyn Announces Entry into Agreement With Progenics Pharmaceuticals, Inc. (PGNX) to Acquire PRO 140 More...
• Idenix Pharmaceuticals, Inc. (IDIX) Regains Drug Rights From Partner Novartis AG (NVS) More...
• PolyMedix Inc. (PYMX.OB) and University of Pennsylvania Collaborate to Develop New Class of Defensin-Mimetic Antimicrobial Compounds to Treat Malaria More...
• Furiex Pharmaceuticals, Inc. (FURX) Announces Closing of Priligy® Asset Transfer and License Agreements More...
• Oncobiologics Inc. Announces a Collaboration Agreement with XOMA Corporation (XOMA) to Utilize XOMA's Fully Human Antibody Libraries for Their Discovery Platform More...
• Anchor Therapeutics Enters Into Collaborative Research Agreement With Kyowa Hakko Kirin for its Pepducin Technology More...
• KV Pharmaceutical CEO Gets Hefty Raise, Despite All the Problems More...
• Soren Tulstrup to Lead Shire plc (SHPG) HGT's MPS Franchise More...
• Cytovance Biologics Inc. Announces Don Wuchterl as Senior Vice President of Manufacturing Operations More...
• Quick-Med Technologies (QMDT) Appoints Bernd Liesenfeld as President More...
• A.P. Pharma, Inc. (APPA) Appoints Robert Rosen to Its Board of Directors More...
• Bayer AG (BAY.F) Lifts Guidance, Provisions Weigh on Earnings More...
• Acura Pharmaceuticals, Inc. (ACUR) Announces Second Quarter 2012 Financial Results More...
• Agennix AG Reports Financial Results for Second Quarter and First Half of 2012 More...
• Amarin Corporation PLC (AMRN) to Report Second Quarter 2012 Financial Results and Host Conference Call on August 8, 2012 More...
• Acasti Pharma First Quarter Results More...
• Teva Pharmaceutical Industries Limited (TEVA) Sues Genzyme Corporation (GENZ) for Poaching Employees More...
• EU Antitrust Charge for Servier, Teva Pharmaceutical Industries Limited (TEVA), Others Over Generics More...
• Immunovative Inc. Announces the Retention of Winston & Strawn LLP as Its Legal Counsel More...
• Vitrolife's Subsidiary in the USA has Been Sued More...